2023
DOI: 10.3389/fchem.2023.1251360
|View full text |Cite
|
Sign up to set email alerts
|

Label-free electrochemical immunosensor as a reliable point-of-care device for the detection of Interleukin-6 in serum samples from patients with psoriasis

Rocco Cancelliere,
Terenzio Cosio,
Elena Campione
et al.

Abstract: Interleukin-6 (IL-6) plays a crucial role in autoimmunity and chronic inflammation. This study aims to develop a low-cost, simple-to-manufacture, and user-friendly label-free electrochemical point-of-care device for the rapid detection of IL-6 in patients with psoriasis. Precisely, a sandwich-based format immunosensor was developed using two primary antibodies (mAb-IL6 clone-5 and clone-7) and screen-printed electrodes modified with an inexpensive recycling electrochemical enhancing material, called biochar. m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(2 citation statements)
references
References 38 publications
0
2
0
Order By: Relevance
“…This is conrmed by DE values, which are always higher than 59 mV, thus suggesting a sluggish electron exchange. 35 This criterion is crucial for recognising Nernstian behaviour and calculating the number of electrons transferred. All platforms in this instance can be classied as a "quasi-reversible" system.…”
Section: Electrochemical Characterisation Of the Electrodesmentioning
confidence: 99%
“…This is conrmed by DE values, which are always higher than 59 mV, thus suggesting a sluggish electron exchange. 35 This criterion is crucial for recognising Nernstian behaviour and calculating the number of electrons transferred. All platforms in this instance can be classied as a "quasi-reversible" system.…”
Section: Electrochemical Characterisation Of the Electrodesmentioning
confidence: 99%
“…Moreover, despite the rapidly growing knowledge regarding cytokines and interleukins' involvement in psoriasis, they prove to be expensive and scarcely available to routinely assess inflammatory state in psoriasis. A clear-cut and prompt analysis of interleukin levels might be offered in the future by validated novel point-of-care devices using label-free electrochemical immunosensors, such as one determining IL-6 levels [10]. As such, a proper identification and comprehensive analysis of simple, low-cost, and widely available markers of systemic inflammation may provide much-needed additional data for a proper diagnosis, assessment, and treatment of patients with psoriasis.…”
Section: Introductionmentioning
confidence: 99%